1-3 of 3
Edwin Haghnazari
Close
Sort by
Journal Articles

Inhibition of overactivated p38 MAPK can restore hematopoiesis in myelodysplastic syndrome progenitors

Tony A. Navas, Mani Mohindru, Myka Estes, Jing Ying Ma, Lubomir Sokol, Perry Pahanish, Simrit Parmar, Edwin Haghnazari, Li Zhou, Robert Collins, Irene Kerr, Aaron N. Nguyen, Yin Xu, Leonidas C. Platanias, Alan A. List, Linda S. Higgins, Amit Verma
Journal: Blood
Blood (2006) 108 (13): 4170–4177.
https://doi.org/10.1182/blood-2006-05-023093
Published: 2006
Journal Articles

Inhibition of p38 MAPK by SCIO-469 Suppresses TNF Generation and Promotes CD34+ Cell Survival in an In Vitro MDS Cell Culture Model.

Tony A. Navas, Ph.D., Aaron N. Nguyen, Ph.D., Jing Y. Ma, M.D., Elizabeth G. Stebbins, Ph.D., Edwin Haghnazari, Ph.D., Ruth Heaton, Alan F. List, M.D., Linda S. Higgins, Ph.D.
Journal: Blood
Blood (2004) 104 (11): 3424.
https://doi.org/10.1182/blood.V104.11.3424.3424
Published: 2004
Journal Articles

SCIO-469, a Potent and Selective Inhibitor of p38a MAPK, Normalizes the Bone Marrow Microenvironment and Inhibits Multiple Myeloma Cell Proliferation in In Vitro and In Vivo Models.

Aaron N. Nguyen, PhD, Mamatha Reddy, MS, Margaret Henson, MS, Elizabeth G. Stebbins, PhD, Gilbert O’Young, BS, Jing Y. Ma, MD, Edwin Haghnazari, PhD, Ann M. Kapoun, PhD, Satya Medicherla, PhD, Andy Protter, PhD, Tony A. Navas, PhD, Linda S. Higgins, PhD
Journal: Blood
Blood (2004) 104 (11): 1501.
https://doi.org/10.1182/blood.V104.11.1501.1501
Published: 2004